NewsEarningsDr. Agarwal's Health Care Reports 71% Jump in Q2 Net Profit, Crosses ₹1,000 Crore Half-Yearly Revenue MilestoneDr. Agarwal's Health Care Reports 71% Jump in Q2 Net Profit, Crosses ₹1,000 Crore Half-Yearly Revenue Milestone
Dr. Agarwal's Health Care Limited, India's largest eye care service chain by revenue, reported robust Q2 FY2026 results. Total income rose 18.2% YoY to ₹507.00 crores, with revenue from operations up 19.7% to ₹499.00 crores. EBITDA grew 21.2% to ₹144.00 crores, while net profit surged 71.0% to ₹36.00 crores. For H1 FY2026, total income crossed ₹1,000 crores, growing 20.2% YoY. The company expanded its network to 258 eye care facilities, adding 24 new centers in H1. It performed 157,281 surgeries, up 14.6% YoY, and served over 1.4 million patients. CEO Dr. Adil Agarwal expressed confidence in meeting annual guidance, citing resilient demand and expansion plans.
*this image is generated using AI for illustrative purposes only.
Dr. Agarwal's Health Care Limited , India's largest eye care service chain by revenue, has reported a robust financial performance for the second quarter of fiscal year 2026, with significant growth in both revenue and profitability.
Q2 FY2026 Highlights
- Total Income: ₹507.00 crores, up 18.2% year-over-year (YoY)
- Revenue from Operations: ₹499.00 crores, a 19.7% YoY increase
- EBITDA: ₹144.00 crores, growing 21.2% YoY with a margin of 28.4%
- Net Profit: ₹36.00 crores, surging 71.0% YoY with a margin of 7.2%
H1 FY2026 Performance
The company's half-yearly results were equally impressive:
- Total Income crossed the ₹1,000 crore milestone, reaching ₹1,007.00 crores, a 20.2% YoY growth
- EBITDA stood at ₹285.00 crores, up 24.9% YoY with a margin of 28.3%
- Net Profit soared to ₹75.00 crores, an 88.4% YoY increase with a margin of 7.4%
Operational Highlights
Dr. Agarwal's Health Care continued its expansion strategy:
- Network expanded to 258 eye care facilities as of September 30, 2025
- Added 24 new centers during H1 FY2026, including 1 tertiary, 13 secondary, and 10 primary facilities
- Performed 157,281 surgeries in H1 FY2026, a 14.6% YoY increase
- Served over 1.4 million patients, supported by a team of 880+ doctors
Financial Performance Breakdown
| Metric (in ₹ Crores) | Q2 FY2026 | Q2 FY2025 | YoY Growth |
|---|---|---|---|
| Total Income | 507.00 | 428.00 | 18.2% |
| Revenue from Operations | 499.00 | 417.00 | 19.7% |
| EBITDA | 144.00 | 119.00 | 21.2% |
| Net Profit | 36.00 | 21.00 | 71.0% |
Management Commentary
Dr. Adil Agarwal, CEO of Dr. Agarwal's Health Care Limited, commented on the results: "The company delivered a steady performance in the first half of FY2026, crossing the INR 1,000 Cr Total Income milestone for the first time — marking a significant achievement in its growth journey. While topline growth moderated compared to the previous quarter due to festivities and heavy rainfall, margins strengthened, demonstrating continued focus on profitability and operational excellence."
He added, "Our recent entry into the Delhi market has seen encouraging traction, and we plan to further accelerate our expansion across North India. We remain confident of meeting our annual guidance, driven by resilient demand and the momentum in our expansion plans."
Future Outlook
The company expects the momentum to build further through FY2026, as the second half of the year typically delivers stronger performance. With its expanding network and focus on operational efficiency, Dr. Agarwal's Health Care appears well-positioned to capitalize on the growing demand for quality eye care services in India and Africa.
Investors and analysts will be watching closely to see if the company can maintain its growth trajectory and continue to improve its profitability in the coming quarters.
